Q1 FY2026 · Press release
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients _ Roivant Sciences Ltd_ · September 3, 2025 · 5 pages
Read Roivant Sciences Ltd.'s results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional
